chr2-127648346-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001161403.3(LIMS2):c.360-5274G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0633 in 298,850 control chromosomes in the GnomAD database, including 693 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.069 ( 395 hom., cov: 31)
Exomes 𝑓: 0.058 ( 298 hom. )
Consequence
LIMS2
NM_001161403.3 intron
NM_001161403.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.210
Genes affected
LIMS2 (HGNC:16084): (LIM zinc finger domain containing 2) This gene encodes a member of a small family of focal adhesion proteins which interacts with ILK (integrin-linked kinase), a protein which effects protein-protein interactions with the extraceullar matrix. The encoded protein has five LIM domains, each domain forming two zinc fingers, which permit interactions which regulate cell shape and migration. A pseudogene of this gene is located on chromosome 4. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2011]
GPR17 (HGNC:4471): (G protein-coupled receptor 17) Predicted to enable G protein-coupled receptor activity. Predicted to be involved in positive regulation of Rho protein signal transduction and positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway. Predicted to act upstream of or within negative regulation of inflammatory response to antigenic stimulus. Predicted to be located in plasma membrane. Predicted to be integral component of plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.106 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LIMS2 | ENST00000355119.9 | c.360-5274G>A | intron_variant | Intron 4 of 9 | 1 | NM_001161403.3 | ENSP00000347240.4 | |||
GPR17 | ENST00000486700.2 | c.-21+2102C>T | intron_variant | Intron 1 of 1 | 1 | NM_001161417.2 | ENSP00000508383.1 |
Frequencies
GnomAD3 genomes AF: 0.0688 AC: 10463AN: 152132Hom.: 392 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
10463
AN:
152132
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0575 AC: 8434AN: 146600Hom.: 298 AF XY: 0.0574 AC XY: 4023AN XY: 70090 show subpopulations
GnomAD4 exome
AF:
AC:
8434
AN:
146600
Hom.:
AF XY:
AC XY:
4023
AN XY:
70090
Gnomad4 AFR exome
AF:
AC:
192
AN:
2734
Gnomad4 AMR exome
AF:
AC:
10
AN:
186
Gnomad4 ASJ exome
AF:
AC:
35
AN:
900
Gnomad4 EAS exome
AF:
AC:
59
AN:
590
Gnomad4 SAS exome
AF:
AC:
308
AN:
2934
Gnomad4 FIN exome
AF:
AC:
1
AN:
40
Gnomad4 NFE exome
AF:
AC:
7482
AN:
134136
Gnomad4 Remaining exome
AF:
AC:
333
AN:
4794
Heterozygous variant carriers
0
402
804
1207
1609
2011
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
394
788
1182
1576
1970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0689 AC: 10494AN: 152250Hom.: 395 Cov.: 31 AF XY: 0.0679 AC XY: 5056AN XY: 74432 show subpopulations
GnomAD4 genome
AF:
AC:
10494
AN:
152250
Hom.:
Cov.:
31
AF XY:
AC XY:
5056
AN XY:
74432
Gnomad4 AFR
AF:
AC:
0.078429
AN:
0.078429
Gnomad4 AMR
AF:
AC:
0.0599922
AN:
0.0599922
Gnomad4 ASJ
AF:
AC:
0.0501441
AN:
0.0501441
Gnomad4 EAS
AF:
AC:
0.113514
AN:
0.113514
Gnomad4 SAS
AF:
AC:
0.113024
AN:
0.113024
Gnomad4 FIN
AF:
AC:
0.0254189
AN:
0.0254189
Gnomad4 NFE
AF:
AC:
0.0661265
AN:
0.0661265
Gnomad4 OTH
AF:
AC:
0.0723746
AN:
0.0723746
Heterozygous variant carriers
0
505
1009
1514
2018
2523
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
130
260
390
520
650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
414
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at